Job Watch

Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)

Funding Opportunity RFA-AR-20-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications that propose to conduct time-sensitive mechanistic ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, ongoing clinical projects. The ongoing parent clinical project can be an interventional clinical trial, or a clinical study such as an observational study that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. Applications submitted in response to this FOA will undergo an accelerated review and award process. The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research communitys understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.

Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)

Funding Opportunity RFA-AR-20-002 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications that propose to conduct time-sensitive mechanistic ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, ongoing clinical projects. The ongoing parent clinical project can be an interventional clinical trial, or a clinical study such as an observational study that will be actively collecting patient samples or clinical data. The parent project(s) should provide a cohort of well-characterized patients, infrastructure, data, and biological samples for the ancillary study. Applications submitted in response to this FOA will undergo an accelerated review and award process. The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research communitys understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.

Senior Scientist, Biomedical Computer Vision - General Electric - Waukesha, WI

Indeed.com - Bioinformatics - Fri, 2019-04-26 06:14
Doctorate in computer science, mathematics, electrical engineering or a related field. GE (NYSE:GE) drives the world forward by tackling its biggest challenges....
From GE Careers - Fri, 26 Apr 2019 10:14:34 GMT - View all Waukesha, WI jobs
Categories: Job Watch

EMBL: DevOps Engineer

New Scientist - Bioinformatics - Fri, 2019-04-26 05:38
Competitive Salary: EMBL: DevOps Engineer Location: EMBL-E Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Bioinformatician

New Scientist - Bioinformatics - Fri, 2019-04-26 05:36
Competitive Salary: EMBL: Bioinformatician Location: EMBL- Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Bioinformatician

New Scientist - Bioinformatics - Fri, 2019-04-26 05:36
Competitive Salary: EMBL: Bioinformatician Location: EMBL- Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Bioinformatician

New Scientist - Bioinformatics - Fri, 2019-04-26 05:36
Competitive Salary: EMBL: Bioinformatician Location: EMBL- Cambridge, Cambridgeshire, England
Categories: Job Watch

Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-261 from the NIH Guide for Grants and Contracts. The NICHD has a state-of-the-art Chemical Synthesis and Optimization Facility for advancing male and/or female non-hormonal contraception developmentwith the capabilities and capacity for preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism, fertility studies). The purpose of this FOA is to provide investigators with a mechanism to request services from this facility that would advance their development program for either male or female contraceptives.

Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed)

Funding Opportunity RFA-DA-20-005 from the NIH Guide for Grants and Contracts. The purpose of this limited competition Funding Opportunity Announcement (FOA) is to support the maintenance and expansion of existing NIDA-funded cohorts to continue addressing new emerging and/or high priority research on multidisciplinary aspects of HIV/AIDS and substance abuse in alignment with NIH-HIV research priorities.

Notice of Change in the NEI K08 Eligibility Requirements

Notice NOT-EY-19-028 from the NIH Guide for Grants and Contracts

Notice of Change in the NEI K23 Eligibility Requirements

Notice NOT-EY-19-027 from the NIH Guide for Grants and Contracts

Two Tenure-track Northwestern Mutual Assistant Professors - Marquette University - Milwaukee, WI

Indeed.com - Bioinformatics - Wed, 2019-04-24 18:23
The Department of Mathematics, Statistics and Computer Science of Marquette University invites applications for two tenure-track Northwestern Mutual Assistant...
From Marquette University - Wed, 24 Apr 2019 22:23:01 GMT - View all Milwaukee, WI jobs
Categories: Job Watch

Pages

Subscribe to Anil Jegga aggregator - Job Watch